000 | 01320 a2200325 4500 | ||
---|---|---|---|
005 | 20250516115318.0 | ||
264 | 0 | _c20130423 | |
008 | 201304s 0 0 eng d | ||
022 | _a1095-8320 | ||
024 | 7 |
_a10.1016/j.biologicals.2012.09.008 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFeavers, Ian | |
245 | 0 | 0 |
_aWHO/Health Canada meeting on regulatory considerations for evaluation and licensing of new meningococcal Group B vaccines, Ottawa, Canada, 3-4 October 2011. _h[electronic resource] |
260 |
_bBiologicals : journal of the International Association of Biological Standardization _cNov 2012 |
||
300 |
_a507-16 p. _bdigital |
||
500 | _aPublication Type: Congress | ||
650 | 0 | 4 | _aGlobal Health |
650 | 0 | 4 | _aLicensure |
650 | 0 | 4 |
_aMeningitis, Meningococcal _xepidemiology |
650 | 0 | 4 |
_aMeningococcal Vaccines _xstandards |
650 | 0 | 4 | _aMolecular Epidemiology |
650 | 0 | 4 | _aOntario |
650 | 0 | 4 | _aWorld Health Organization |
700 | 1 | _aGriffiths, Elwyn | |
700 | 1 | _aBaca-Estrada, Maria | |
700 | 1 | _aKnezevic, Ivana | |
700 | 1 | _aZhou, TieQun | |
773 | 0 |
_tBiologicals : journal of the International Association of Biological Standardization _gvol. 40 _gno. 6 _gp. 507-16 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biologicals.2012.09.008 _zAvailable from publisher's website |
999 |
_c22195539 _d22195539 |